Results 1 to 10 of about 5,134 (265)

Real-world utilization pattern of dydrogesterone in 7287 Indian women with obstetric and gynecological conditions: data from multicentric, retrospective study [PDF]

Revista Brasileira de Ginecologia e Obstetrícia
Objective: Despite the literature on dydrogesterone, studies on dydrogesterone utilization patterns are largely lacking in Indian patients. Methods: This was a multi-center, retrospective, observational, cross-sectional, and descriptive study across 817
Jaydeep Tank, Sanjay Gupte, Purna Chandra Mahapatra, Jayanthi Reddy, Pratima Mittal, Ashish Kumar Mukhopadhyay, Lila Vyas, Achla Batra, Mahesh Gupta, Sunita Tandulwadkar, Sunita Chandra, Vidya Bhat, Kawita Bapat, Parikshit Tank, Ketan Kulkarni, Onkar Swami   +15 more
doaj   +3 more sources

Supplementary dydrogesterone is beneficial as luteal phase support in artificial frozen-thawed embryo transfer cycles compared to micronized progesterone alone [PDF]

Frontiers in Endocrinology, 2023
IntroductionThe number of frozen embryo transfers increased substantially in recent years. To increase the chances of implantation, endometrial receptivity and embryo competency must be synchronized.
Angela Vidal, Carolin Dhakal, Nathalie Werth, Jürgen Michael Weiss, Dirk Lehnick, Alexandra Sabrina Kohl Schwartz, Alexandra Sabrina Kohl Schwartz   +6 more
doaj   +4 more sources

Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation? [PDF]

Reprod Biol Endocrinol
Research question To determine whether the use of oral dydrogesterone (DYD) in luteal phase support (LPS) during an artificial cycle provides equivalent clinical and ongoing pregnancy, delivery and miscarriage rates as micronized vaginal progesterone ...
Lorillon M, Robin G, Keller L, Cailliau E, Delcourt C, Simon V, Decanter C, Catteau-Jonard S.   +7 more
europepmc   +3 more sources

A multicentre phase III study comparing efficacy and safety of novel extended-release versus conventional formulation of dydrogesterone in Indian patients with endometriosis [PDF]

International Journal of Reproduction Contraception Obstetrics and Gynecology
Background: The aim of the study was to compare the efficacy and safety of novel once-daily extended-release (ER) dydrogesterone 20 mg versus conventional twice-daily dydrogesterone 10 mg in Indian patients with endometriosis.
Agarwal, Mukta, Bawa, Deepti, Chinda, Monika, Daultani, Pavankumar, Jain, Vandana, Jaiswal, Ashok, Kushwaha, Shikha, Narayan, Suchitra, Sasikala, T., Singh, Anit   +9 more
core   +4 more sources

Comparison of the effect of dydrogesterone and natural micronized progesterone for luteal-phase support in assisted reproductive technology cycles: A single-blind randomized clinical trial study. [PDF]

Health Sci Rep
Background and Aims One of the causes of preterm labor and recurrent abortion is progesterone deficiency in the luteal phase. The aim of the study was a comparison of the effect of oral dydrogesterone and vaginal progesterone for luteal‐phase support ...
Atarieh M, Javadian M, Basirat Z, Kashifard M, Yazdani S, Adib-Rad H, Abdollahzade-Delavar M, Gholinia H.   +7 more
europepmc   +3 more sources

No improvement in pregnancy and perinatal outcomes with combined luteal support in modified natural cycle frozen embryo transfer [PDF]

Frontiers in Endocrinology
ObjectiveWe investigated whether the addition of a luteal phase support drug benefits pregnancy and perinatal outcomes in modified natural-cycle frozen-thawed embryo transfer (mNC-FET) for women up to the age of 35 years.MethodsWe analyzed the clinical ...
Wen Zhang, Sheling Wu, Bingnan Ren, Ruolin Jia, Wenjuan Zhang, Bijun Wang, Xiaofang Du, Yichun Guan   +7 more
doaj   +2 more sources

Real-World Evidence of Dydrogesterone 20 mg and 30 mg SR Usage in Pregnancy. [PDF]

Cureus
Background Dydrogesterone, an oral selective progesterone receptor agonist with high bioavailability, has been used since the 1960s to treat various conditions arising due to the deficiency of progesterone.
Manickavasagam M, Vakil A, Singh E, Roy H, Lal N, Patel RG, Mishra R, Gudibanda S, Shah S.   +8 more
europepmc   +2 more sources

Evaluation of allylestrenol for clinical pregnancies in patients treated with assisted reproductive techniques: a retrospective, propensity score matched, observational study [PDF]

BMC Pregnancy and Childbirth, 2023
Background Allylestrenol is an oral progestogen being increasingly used for luteal phase support in assisted reproductive techniques. However, evidence of the clinical efficacy of allylestrenol in luteal phase support is lacking.
Yuexin Yu, Tingting Yu, Weiping Ding, Yinling Xiu, Mengsi Zhao, Kaixuan Sun, Qian Zhang, Xiaohang Xu   +7 more
doaj   +2 more sources

Comparison of pregnancy outcome after adding oral or intramuscular progesterone to vaginal progesterone in frozen embryo transfer: A cross-sectional study [PDF]

International Journal of Reproductive BioMedicine
Background: Currently, frozen embryo transfers (FET) account for 41% of all embryo transfer cycles. Vaginal progesterone preparations have become the leading choice for luteal phase support due to their convenient application; however, using only ...
Sahereh Arabian, Maryam Eftekhar, Saeideh Dashti, Nahid Homayoon, Elham Nikfarjam   +4 more
doaj   +2 more sources

No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis. [PDF]

Hum Reprod Open
STUDY QUESTION Is exposure to dydrogesterone a risk factor for congenital anomalies when given in the first trimester for recurrent/threatened pregnancy loss or as luteal support in assisted reproductive technology (ART)?
Katalinic A, Noftz MR, Garcia-Velasco JA, Shulman LP, van den Anker JN, Strauss Iii JF.   +5 more
europepmc   +2 more sources